Figure 1: Annual NIH Funding in Human Microbiome Research, FY2007-FY2016
Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Human Microbiome Sequencing Market
Figure 3: Global Human Microbiome Sequencing Market (by Product), 2018 vs. 2029 ($Million)
Figure 4: Global Human Microbiome Sequencing Market (by Technology), 2018 vs. 2029 ($Million)
Figure 5: Global Human Microbiome Sequencing Market (by Application), 2018 vs. 2029 ($Million)
Figure 6: Global Human Microbiome Sequencing Market (by End User), 2018 vs. 2029 ($Million)
Figure 7: Global Human Microbiome Sequencing Market Snapshot
Figure 2.1: Global Human Microbiome Sequencing Market Segmentation
Figure 2.2: Global Human Microbiome Sequencing Market Methodology
Figure 3.1: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.2: Top-Down Approach (Segment-Wise Analysis)
Figure 5.1: Share of Key Developments and Strategies, January 2016–February 2020
Figure 5.2: Synergistic Activities Share (by Company), January 2016–February 2020
Figure 5.3: Product Launches Share (by Company), January 2016 – February 2020
Figure 5.4: Business Expansion Activities Share (by Company), January 2016 – February 2020
Figure 5.5: Market Share Analysis for Global Human Microbiome Sequencing Market, 2017 and 2018
Figure 5.6: Growth Share Analysis for Global Human Microbiome Sequencing Market (by Company), 2018
Figure 5.7: Growth Share Analysis for Global Human Microbiome Sequencing Market (by Application), 2018-2029
Figure 6.1: Iceberg Analysis - Global Human Microbiome Sequencing Market
Figure 6.2: Impact Analysis
Figure 6.3: Annual NIH Funding in the Human Microbiome Research, FY2007-FY2016
Figure 6.4: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 7.1: Milestones in Human Microbiota Research
Figure 7.2: Global Human Microbiome Sequencing Market, 2018-2029
Figure 8.1: Global Human Microbiome Sequencing Market (by Product Type)
Figure 8.2: Global Human Microbiome Sequencing Market (by Product Type), 2018 and 2029
Figure 8.3: Global Human Microbiome Sequencing Market (by Kits and Assays), 2018-2029
Figure 8.4: Global Human Microbiome Sequencing Market (by Instruments), 2018-2029
Figure 8.5: Global Human Microbiome Sequencing Market (by Software), 2018-2029
Figure 9.1: Global Human Microbiome Sequencing Market (by Technology)
Figure 9.2: Global Human Microbiome Sequencing Market (by Technology), 2018-2029
Figure 9.3: Global Human Microbiome Sequencing Market (by Next-Generation Sequencing), 2018 and 2029
Figure 9.4: Global Human Microbiome Sequencing Market (by Sequencing by Synthesis), 2018-2029
Figure 9.5: Global Human Microbiome Sequencing Market (by Sequencing by Ligation), 2018-2029
Figure 9.6: Global Human Microbiome Sequencing Market (by Other Next-Generation Sequencing Technologies), 2018-2029
Figure 9.7: Global Human Microbiome Sequencing Market (by Traditional Sequencing Technologies), 2018 and 2029
Figure 9.8: Global Human Microbiome Sequencing Market (by Pyrosequencing), 2018-2029
Figure 9.9: Global Human Microbiome Sequencing Market (by Sanger Sequencing), 2018-2029
Figure 9.10: Global Human Microbiome Sequencing Market (by Other Sequencing Technologies), 2018-2029
Figure 10.1: Global Human Microbiome Sequencing Market (by Application)
Figure 10.2: Global Human Microbiome Sequencing Market (by Application), 2018-2029
Figure 10.3: Global Human Microbiome Sequencing Market (by Disease Diagnosis), 2018 and 2029
Figure 10.4: Global Human Microbiome Sequencing Market (Gastrointestinal Disease), 2018-2029
Figure 10.5: Global Human Microbiome Sequencing Market (by Metabolic Diseases), 2018-2029
Figure 10.6: Global Human Microbiome Sequencing Market (by Oncology), 2018-2029
Figure 10.7: Global Human Microbiome Sequencing Market (Infectious Diseases), 2018-2029
Figure 10.8: Global Human Microbiome Sequencing Market (Neurological Diseases), 2018-2029
Figure 10.9: Global Human Microbiome Sequencing Market (Other Diseases), 2018-2029
Figure 10.10: Global Human Microbiome Sequencing Market (by Drug Discovery), 2018-2029
Figure 10.11: Global Human Microbiome Sequencing Market (by Drug Discovery), 2018-2029
Figure 10.12: Global Human Microbiome Sequencing Market (by Omics Analysis), 2018 and 2029
Figure 10.13: Global Human Microbiome Sequencing Market (by Genome Analysis),2018-2029
Figure 10.14: Global Human Microbiome Sequencing Market (by Metabolome Analysis), 2018-2029
Figure 10.15: Global Human Microbiome Sequencing Market (by Transcriptome Analysis), 2018-2029
Figure 10.16: Global Human Microbiome Sequencing Market (by Other Omics Analysis), 2018-2029
Figure 10.17: Global Human Microbiome Sequencing Market (by Other Applications), 2018-2029
Figure 11.1: Global Human Microbiome Sequencing Market (by End User)
Figure 11.2: Global Human Microbiome Sequencing Market (by Research and Academic Institutions), 2018-2029
Figure 11.3: Global Human Microbiome Sequencing Market (by Pharmaceutical and Biotechnology Companies), 2018-2029
Figure 11.4: Global Human Microbiome Sequencing Market (by Other End Users), 2018-2029
Figure 12.1: Global Human Microbiome Sequencing Market (by Region)
Figure 12.2: Global Human Microbiome Sequencing Market (by Region), 2018-2029
Figure 12.3: Global Human Microbiome Sequencing Market Share (by Region), 2018 and 2029
Figure 12.4: North America Human Microbiome Sequencing Market, 2018-2029
Figure 12.5: North America: Market Dynamics
Figure 12.6: North America Human Microbiome Sequencing Market (by Country), 2018-2029
Figure 12.7: U.S. Human Microbiome Sequencing Market, 2018-2029
Figure 12.8: Canada Human Microbiome Sequencing Market, 2018-2029
Figure 12.9: Europe Human Microbiome Sequencing Market, 2018-2029
Figure 12.10: Europe: Market Dynamics
Figure 12.11: Europe Human Microbiome Sequencing Market (by Country), 2018-2029
Figure 12.12: Germany Human Microbiome Sequencing Market, 2018-2029
Figure 12.13: France Human Microbiome Sequencing Market, 2018-2029
Figure 12.14: U.K. Human Microbiome Sequencing Market, 2018-2029
Figure 12.15: Spain Human Microbiome Sequencing Market, 2018-2029
Figure 12.16: Italy Human Microbiome Sequencing Market, 2018-2029
Figure 12.17: Russia Human Microbiome Sequencing Market, 2018-2029
Figure 12.18: Rest-of-Europe Human Microbiome Sequencing Market, 2018-2029
Figure 12.19: Asia-Pacific Human Microbiome Sequencing Market, 2018-2029
Figure 12.20: APAC: Market Dynamics
Figure 12.21: APAC Human Microbiome Sequencing Market (by Country), 2018-2029
Figure 12.22: China Human Microbiome Sequencing Market, 2018-2029
Figure 12.23: Japan Human Microbiome Sequencing Market, 2018-2029
Figure 12.24: India Human Microbiome Sequencing Market, 2018-2029
Figure 12.25: Australia Human Microbiome Sequencing Market, 2018-2029
Figure 12.26: South Korea Human Microbiome Sequencing Market, 2018-2029
Figure 12.27: Singapore Human Microbiome Sequencing Market, 2018-2029
Figure 12.28: RoAPAC Human Microbiome Sequencing Market, 2018-2029
Figure 12.29: Latin America Human Microbiome Sequencing Market, 2018-2029
Figure 12.30: Latin America: Market Dynamics
Figure 12.31: Latin America Human Microbiome Sequencing Market (by Country), 2018-2029
Figure 12.32: Brazil Human Microbiome Sequencing Market, 2018-2029
Figure 12.33: Mexico Human Microbiome Sequencing Market, 2018-2029
Figure 12.34: Argentina Human Microbiome Sequencing Market, 2018-2029
Figure 12.35: Rest-of-Latin America Human Microbiome Sequencing Market, 2018-2029
Figure 12.36: RoW Human Microbiome Sequencing Market, 2018-2029
Figure 13.1: Global Human Microbiome Sequencing Market: Value Chain
Figure 13.2: Baseclear B.V.: Overall Service Portfolio
Figure 13.3: Baseclear B.V.: SWOT Analysis
Figure 13.4: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Service Portfolio
Figure 13.5: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Financials, 2017-2018
Figure 13.6: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Sales (by Segment), 2017-2018
Figure 13.7: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Sales (by Region), 2017-2018
Figure 13.8: Beijing Genomics Institute (BGI) Genomics Co., Ltd: R&D Expenditure, 2017-2018
Figure 13.9: Beijing Genomics Institute (BGI) Genomics Co., Ltd: SWOT Analysis
Figure 13.10: Charles River Laboratories International Inc.: Overall Service Portfolio
Figure 13.11: Charles River Laboratories International Inc.: Overall Financials, 2016-2018
Figure 13.12: Charles River Laboratories International Inc.: Revenue (by Segment), 2016-2018
Figure 13.13: Charles River Laboratories International Inc.: Revenue (by Region), 2016-2018
Figure 13.14: Charles River Laboratories International Inc.: SWOT Analysis
Figure 13.15: Clinical Microbiomics A/S: Service Offerings
Figure 13.16: Clinical Microbiomics A/S: SWOT Analysis
Figure 13.17: Eurofins Scientific SE: Service Portfolio
Figure 13.18: Eurofins Scientific SE: Overall Financials, 2016-2018
Figure 13.19: Eurofins Scientific SE: Revenue (by Region), 2016-2018
Figure 13.20: Eurofins Scientific SE.: SWOT Analysis
Figure 13.21: GENEWIZ, Inc.: Overall Service Portfolio
Figure 13.22: GENEWIZ, Inc.: SWOT Analysis
Figure 13.23: Illumina, Inc.: Overall Product Portfolio
Figure 13.24: Illumina, Inc.: Overall Financials, 2016-2018
Figure 13.25: Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 13.26: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 13.27: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 13.28: Illumina, Inc.: SWOT Analysis
Figure 13.29: Novogene Corporation: Overall Service Portfolio
Figure 13.30: Novogene Corporation: SWOT Analysis
Figure 13.31: OraSure Technologies, Inc.: Overall Service Portfolio
Figure 13.32: OraSure Technologies, Inc.: Overall Financials, 2016-2018
Figure 13.33: OraSure Technologies, Inc.: Sales (by Segment), 2016-2018
Figure 13.34: OraSure Technologies, Inc.: Sales (by Region), 2016-2018
Figure 13.35: OraSure Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 13.36: OraSure Technologies, Inc.: SWOT Analysis
Figure 13.37: Oxford Nanopore Technologies, Inc.: Product Offerings
Figure 13.38: Oxford Nanopore Technologies, Inc.: SWOT Analysis
Figure 13.39: Pacific Biosciences of California, Inc.: Overall Product Portfolio
Figure 13.40: Pacific Biosciences of California, Inc.: Overall Financials, 2016-2018
Figure 13.41: Pacific Biosciences of California, Inc.: Revenue (by Segment), 2016-2018
Figure 13.42: Pacific Biosciences of California, Inc.: Revenue (by Region), 2016-2018
Figure 13.43: Pacific Biosciences of California, Inc.: R&D Expenditure, 2016-2018
Figure 13.44: Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 13.45: QIAGEN N.V.: Overall Product Portfolio
Figure 13.46: QIAGEN N.V.: Overall Financials, 2016-2018
Figure 13.47: QIAGEN N.V.: Revenue (by Segment), 2016-2018
Figure 13.48: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 13.49: QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 13.50: QIAGEN N.V.: SWOT Analysis
Figure 13.51: Second Genome, Inc.: Service Offerings
Figure 13.52: Second Genome, Inc.: SWOT Analysis
Figure 13.53: Thermo Fisher Scientific Inc.: Overall Product and Service Portfolio
Figure 13.54: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 13.55: Thermo Fisher Scientific Inc: Sales (by Segment), 2016-2018
Figure 13.56: Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
Figure 13.57: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 13.58: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 13.59: Viome, Inc.: Product Offerings
Figure 13.60: Viome, Inc.: SWOT Analysis
Figure 13.61: CosmosID: Service Offerings
Figure 13.62: Leucine Rich Bio Pvt. Ltd.: Service Offerings
Figure 13.63: Microba: Service Offerings
Figure 13.64: Microbiome Insights Inc.: Service Offerings
Figure 13.65: Molzym GmbH & Co. KG: Product Offerings